Hemanext will be exhibiting at the upcoming Remote Damage Control Resuscitation (RDCR) Symposium, taking place June 23 – 26, 2019 in Osøyro, Norway. The RDCR Symposium is organized by THOR – The Hemostasis and Oxygen Research Network. THOR is an international multidisciplinary group of investigators with the aim to improve outcomes and safety in patients with severe traumatic injury through improved monitoring and resuscitation techniques. This Symposium brings together investigators and thought leaders from around the world to present the most current research and discuss the latest issues in traumatic hemorrhagic shock. Hemanext is proud to sponsor THOR in its mission to optimize methods to identify and treat traumatic shock.
Recent Posts
- Hemanext Expands Board of Directors with Two New Members
- Hemanext Announces Close of Series B-2 Equity Funding Round
- Hemanext Inc. Announces First Patients Treated In A Clinical Trial Investigating the Efficacy of the Hemanext ONE® Red Blood Cell Processing and Storage System
- Hemanext signs agreement with Hemara Bio, a healthcare distributor in the U.A.E., to provide hospitals and clinicians across the GCC Region with Hemanext ONE® system
- Hemanext Inc. Announces New HCPCS Code for “Red Blood Cells, Leukocytes Reduced, Oxygen/Carbon Dioxide Reduced, Each Unit.”